4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022051
Sr. VP & CMO sold 534 shares at $9.63 ($5,142)
From the SEC's structured data for this filing
Trades in this filing
Rottinghaus Scott T. · Sr. VP & CMO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-05 | Sale : show line 1 in the form | −534 | $9.63 | $5,142 | 26,466 | D |
| Open-market sales · 534 sh · avg $9.63 · $5,142 | ||||||
Loading xslF345X05/form4.xml…